_id
69109627ccc777a4e85d5b3a
Ticker
ELTX
Name
Elicio Therapeutics Inc.
Exchange
NASDAQ
Address
451 D Street, Boston, MA, United States, 02210
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://elicio.com
Description
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Last Close
8.07
Volume
72694
Current Price
7.96
Change
0.09
Last Updated
2026-01-03T10:55:45.246Z
Image
data:image/webp;base64,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
Ipo Date
2021-02-05T00:00:00.000Z
Market Cap
138932144
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-0.0040000000000000036
Sentiment Sources
2
Rating
4.5
Target Price
15.5
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
283000
Gross Profit
-283000
Operating Expenses
7762000
Operating Income
-8045000
Interest Expense
426000
Pretax Income
-10083000
Net Income
-10083000
Eps
-0.6040446006931506
Dividends Per Share
-
Shares Outstanding
17258652
Income Tax Expense
-
EBITDA
-9374000
Operating Margin
-
Total Other Income Expense Net
-2038000
Cash
20611000
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
21465000
Property Plant Equipment
5347000
Total Assets
28284000
Payables
321000
Short Term Debt
981000
Long Term Debt
9720000
Total Liabilities
24468000
Equity
3816000
Bs_currency_symbol
USD
Depreciation
283000
Change In Working Capital
-4179000
Cash From Operations
-11086000
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
9572000
Net Change In Cash
-1477000
Cf_currency_symbol
USD
PE
-
PB
34.8197350524109
ROE
-264.2295597484277
ROA
-35.6491302503182
FCF
-11086000
Fcf Percent
-
Piotroski FScore
0
Health Score
16
Deep Value Investing Score
2.5
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.3
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
1
Quality Investing Score
1.5
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
283000
Quarters > 0 > income Statement > gross Profit
-283000
Quarters > 0 > income Statement > operating Expenses
7762000
Quarters > 0 > income Statement > operating Income
-8045000
Quarters > 0 > income Statement > interest Expense
426000
Quarters > 0 > income Statement > pretax Income
-10083000
Quarters > 0 > income Statement > net Income
-10083000
Quarters > 0 > income Statement > eps
-0.6040446006931506
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16692476
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-9374000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-2038000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
20611000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
21465000
Quarters > 0 > balance Sheet > property Plant Equipment
5347000
Quarters > 0 > balance Sheet > total Assets
28284000
Quarters > 0 > balance Sheet > payables
321000
Quarters > 0 > balance Sheet > short Term Debt
981000
Quarters > 0 > balance Sheet > long Term Debt
9720000
Quarters > 0 > balance Sheet > total Liabilities
24468000
Quarters > 0 > balance Sheet > equity
3816000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-10083000
Quarters > 0 > cash Flow > depreciation
283000
Quarters > 0 > cash Flow > change In Working Capital
-4179000
Quarters > 0 > cash Flow > cash From Operations
-11086000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
9572000
Quarters > 0 > cash Flow > net Change In Cash
-1477000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.6040446006931506
Quarters > 0 > ratios > PB
34.8197350524109
Quarters > 0 > ratios > ROE
-264.2295597484277
Quarters > 0 > ratios > ROA
-35.6491302503182
Quarters > 0 > ratios > FCF
-11086000
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
16
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
281000
Quarters > 1 > income Statement > gross Profit
-281000
Quarters > 1 > income Statement > operating Expenses
10091000
Quarters > 1 > income Statement > operating Income
-10091000
Quarters > 1 > income Statement > interest Expense
194000
Quarters > 1 > income Statement > pretax Income
-10561000
Quarters > 1 > income Statement > net Income
-10561000
Quarters > 1 > income Statement > eps
-0.657620139901664
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16059423
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-10086000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-470000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
22088000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
22598000
Quarters > 1 > balance Sheet > property Plant Equipment
5630000
Quarters > 1 > balance Sheet > total Assets
29528000
Quarters > 1 > balance Sheet > payables
3865000
Quarters > 1 > balance Sheet > short Term Debt
952000
Quarters > 1 > balance Sheet > long Term Debt
9337000
Quarters > 1 > balance Sheet > total Liabilities
27694000
Quarters > 1 > balance Sheet > equity
1834000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-10561000
Quarters > 1 > cash Flow > depreciation
281000
Quarters > 1 > cash Flow > change In Working Capital
-351000
Quarters > 1 > cash Flow > cash From Operations
-8950000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
11932000
Quarters > 1 > cash Flow > net Change In Cash
3056000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.657620139901664
Quarters > 1 > ratios > PB
69.70174868047982
Quarters > 1 > ratios > ROE
-575.845147219193
Quarters > 1 > ratios > ROA
-35.76605256028177
Quarters > 1 > ratios > FCF
-8950000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
17
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
278000
Quarters > 2 > income Statement > gross Profit
-278000
Quarters > 2 > income Statement > operating Expenses
10458000
Quarters > 2 > income Statement > operating Income
-10736000
Quarters > 2 > income Statement > interest Expense
176000
Quarters > 2 > income Statement > pretax Income
-11209000
Quarters > 2 > income Statement > net Income
-11209000
Quarters > 2 > income Statement > eps
-0.8655214819049719
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
12950574
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-10755000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-473000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
18351000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
20935000
Quarters > 2 > balance Sheet > property Plant Equipment
5911000
Quarters > 2 > balance Sheet > total Assets
28144000
Quarters > 2 > balance Sheet > payables
4037000
Quarters > 2 > balance Sheet > short Term Debt
926000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
19240000
Quarters > 2 > balance Sheet > equity
8904000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-11209000
Quarters > 2 > cash Flow > depreciation
278000
Quarters > 2 > cash Flow > change In Working Capital
-354000
Quarters > 2 > cash Flow > cash From Operations
-10119000
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
10328000
Quarters > 2 > cash Flow > net Change In Cash
240000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.8655214819049719
Quarters > 2 > ratios > PB
11.577557169811321
Quarters > 2 > ratios > ROE
-125.88724168912849
Quarters > 2 > ratios > ROA
-39.82731665719159
Quarters > 2 > ratios > FCF
-10119000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
1166000
Quarters > 3 > income Statement > cost Of Revenue
305000
Quarters > 3 > income Statement > gross Profit
-305000
Quarters > 3 > income Statement > operating Expenses
13171000
Quarters > 3 > income Statement > operating Income
-13476000
Quarters > 3 > income Statement > interest Expense
234000
Quarters > 3 > income Statement > pretax Income
-14004000
Quarters > 3 > income Statement > net Income
-14004000
Quarters > 3 > income Statement > eps
-1.1475870351838189
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12202996
Quarters > 3 > income Statement > income Tax Expense
-36000
Quarters > 3 > income Statement > EBITDA
-13465000
Quarters > 3 > income Statement > operating Margin
-1155.746140651801
Quarters > 3 > income Statement > total Other Income Expense Net
-528000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
17618000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
20693000
Quarters > 3 > balance Sheet > property Plant Equipment
6189000
Quarters > 3 > balance Sheet > total Assets
28178000
Quarters > 3 > balance Sheet > payables
1038000
Quarters > 3 > balance Sheet > short Term Debt
901000
Quarters > 3 > balance Sheet > long Term Debt
20034000
Quarters > 3 > balance Sheet > total Liabilities
39490000
Quarters > 3 > balance Sheet > equity
-11312000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-14004000
Quarters > 3 > cash Flow > depreciation
305000
Quarters > 3 > cash Flow > change In Working Capital
3685000
Quarters > 3 > cash Flow > cash From Operations
-8744000
Quarters > 3 > cash Flow > capital Expenditures
45000
Quarters > 3 > cash Flow > cash From Investing
-45000
Quarters > 3 > cash Flow > cash From Financing
227000
Quarters > 3 > cash Flow > net Change In Cash
-8535000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-1.1475870351838189
Quarters > 3 > ratios > PB
-8.586973847241866
Quarters > 3 > ratios > ROE
123.7977369165488
Quarters > 3 > ratios > ROA
-49.69834622755341
Quarters > 3 > ratios > FCF
-8789000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-7.537735849056604
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
1178000
Annuals > 0 > income Statement > gross Profit
-1178000
Annuals > 0 > income Statement > operating Expenses
43808000
Annuals > 0 > income Statement > operating Income
-44986000
Annuals > 0 > income Statement > interest Expense
455000
Annuals > 0 > income Statement > pretax Income
-51898000
Annuals > 0 > income Statement > net Income
-51898000
Annuals > 0 > income Statement > eps
-4.252890027989848
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12202996
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-50265000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-6912000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
17618000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
20693000
Annuals > 0 > balance Sheet > property Plant Equipment
6189000
Annuals > 0 > balance Sheet > total Assets
28178000
Annuals > 0 > balance Sheet > payables
1038000
Annuals > 0 > balance Sheet > short Term Debt
901000
Annuals > 0 > balance Sheet > long Term Debt
20034000
Annuals > 0 > balance Sheet > total Liabilities
39490000
Annuals > 0 > balance Sheet > equity
-11312000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-51898000
Annuals > 0 > cash Flow > depreciation
1178000
Annuals > 0 > cash Flow > change In Working Capital
3959000
Annuals > 0 > cash Flow > cash From Operations
-37068000
Annuals > 0 > cash Flow > capital Expenditures
87000
Annuals > 0 > cash Flow > cash From Investing
-84000
Annuals > 0 > cash Flow > cash From Financing
42321000
Annuals > 0 > cash Flow > net Change In Cash
5191000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-4.252890027989848
Annuals > 0 > ratios > PB
-8.684062747524754
Annuals > 0 > ratios > ROE
458.78712871287127
Annuals > 0 > ratios > ROA
-184.17914685215416
Annuals > 0 > ratios > FCF
-37155000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
1170000
Annuals > 1 > income Statement > gross Profit
-1170000
Annuals > 1 > income Statement > operating Expenses
34575000
Annuals > 1 > income Statement > operating Income
-35745000
Annuals > 1 > income Statement > interest Expense
1059000
Annuals > 1 > income Statement > pretax Income
-35195000
Annuals > 1 > income Statement > net Income
-35195000
Annuals > 1 > income Statement > eps
-6.960726629056262
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5056225
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-32966000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
550000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
12894000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
16348000
Annuals > 1 > balance Sheet > property Plant Equipment
7280000
Annuals > 1 > balance Sheet > total Assets
27146000
Annuals > 1 > balance Sheet > payables
4369000
Annuals > 1 > balance Sheet > short Term Debt
910000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
15773000
Annuals > 1 > balance Sheet > equity
11373000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-35195000
Annuals > 1 > cash Flow > depreciation
1170000
Annuals > 1 > cash Flow > change In Working Capital
-57000
Annuals > 1 > cash Flow > cash From Operations
-32694000
Annuals > 1 > cash Flow > capital Expenditures
66000
Annuals > 1 > cash Flow > cash From Investing
-32000
Annuals > 1 > cash Flow > cash From Financing
38613000
Annuals > 1 > cash Flow > net Change In Cash
5887000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-6.960726629056262
Annuals > 1 > ratios > PB
3.578880792227205
Annuals > 1 > ratios > ROE
-309.4610041325947
Annuals > 1 > ratios > ROA
-129.6507772784204
Annuals > 1 > ratios > FCF
-32760000
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
19
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
1057000
Annuals > 2 > income Statement > gross Profit
-1057000
Annuals > 2 > income Statement > operating Expenses
22676000
Annuals > 2 > income Statement > operating Income
-23733000
Annuals > 2 > income Statement > interest Expense
3595838
Annuals > 2 > income Statement > pretax Income
-28208000
Annuals > 2 > income Statement > net Income
-28208000
Annuals > 2 > income Statement > eps
-9.099354838709678
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
3100000
Annuals > 2 > income Statement > income Tax Expense
3595838
Annuals > 2 > income Statement > EBITDA
-23554000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-4475000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
7797000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
4219838
Annuals > 2 > balance Sheet > total Current Assets
10717000
Annuals > 2 > balance Sheet > property Plant Equipment
8497000
Annuals > 2 > balance Sheet > total Assets
22664000
Annuals > 2 > balance Sheet > payables
2805000
Annuals > 2 > balance Sheet > short Term Debt
692000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
13749000
Annuals > 2 > balance Sheet > equity
8915000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-28208000
Annuals > 2 > cash Flow > depreciation
1057000
Annuals > 2 > cash Flow > change In Working Capital
-150000
Annuals > 2 > cash Flow > cash From Operations
-22179000
Annuals > 2 > cash Flow > capital Expenditures
654000
Annuals > 2 > cash Flow > cash From Investing
-654000
Annuals > 2 > cash Flow > cash From Financing
21202000
Annuals > 2 > cash Flow > net Change In Cash
-1631000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-9.099354838709678
Annuals > 2 > ratios > PB
2.799214806505889
Annuals > 2 > ratios > ROE
-316.41054402692095
Annuals > 2 > ratios > ROA
-124.46170137663255
Annuals > 2 > ratios > FCF
-22833000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
28312000
Annuals > 3 > income Statement > cost Of Revenue
1234000
Annuals > 3 > income Statement > gross Profit
27078000
Annuals > 3 > income Statement > operating Expenses
66385000
Annuals > 3 > income Statement > operating Income
-39307000
Annuals > 3 > income Statement > interest Expense
876442
Annuals > 3 > income Statement > pretax Income
-54573000
Annuals > 3 > income Statement > net Income
-26400698
Annuals > 3 > income Statement > eps
-8.250218125
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
3200000
Annuals > 3 > income Statement > income Tax Expense
876442
Annuals > 3 > income Statement > EBITDA
-51925000
Annuals > 3 > income Statement > operating Margin
-138.83512291607798
Annuals > 3 > income Statement > total Other Income Expense Net
-15266000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
88756000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
806000
Annuals > 3 > balance Sheet > inventories
188957
Annuals > 3 > balance Sheet > total Current Assets
91247000
Annuals > 3 > balance Sheet > property Plant Equipment
4437000
Annuals > 3 > balance Sheet > total Assets
96513000
Annuals > 3 > balance Sheet > payables
4710000
Annuals > 3 > balance Sheet > short Term Debt
952000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
15006000
Annuals > 3 > balance Sheet > equity
81507000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-26400697
Annuals > 3 > cash Flow > depreciation
251451
Annuals > 3 > cash Flow > change In Working Capital
872435
Annuals > 3 > cash Flow > cash From Operations
-23939045
Annuals > 3 > cash Flow > capital Expenditures
525359
Annuals > 3 > cash Flow > cash From Investing
-525359
Annuals > 3 > cash Flow > cash From Financing
19393568
Annuals > 3 > cash Flow > net Change In Cash
-5070836
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-8.250218125
Annuals > 3 > ratios > PB
0.31604647453592943
Annuals > 3 > ratios > ROE
-32.390712454145046
Annuals > 3 > ratios > ROA
-27.35455120035643
Annuals > 3 > ratios > FCF
-24464404
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-0.8641001695394179
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.6040446006931506
Valuation > metrics > PB
34.8197350524109
Valuation > final Score
20
Valuation > verdict
1060.7% Overvalued
Profitability > metrics > ROE
-264.2295597484277
Profitability > metrics > ROA
-46.974143955276034
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
6.411949685534591
Risk > metrics > Interest Coverage
-18.884976525821596
Risk > final Score
-70
Risk > verdict
High
Liquidity > metrics > Current Ratio
16.486175115207374
Liquidity > metrics > Quick Ratio
16.486175115207374
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
20
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
40
Prev Risks > 0
-202
Prev Risks > 1
-226
Prev Risks > 2
-200
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:46:18.969Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-13
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.6
Earnings History > 0 > eps Estimate
-0.68
Earnings History > 0 > eps Difference
0.08
Earnings History > 0 > surprise Percent
11.7647
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-07
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.66
Earnings History > 1 > eps Estimate
-0.67
Earnings History > 1 > eps Difference
0.01
Earnings History > 1 > surprise Percent
1.4925
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-13
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.87
Earnings History > 2 > eps Estimate
-0.73
Earnings History > 2 > eps Difference
-0.14
Earnings History > 2 > surprise Percent
-19.1781
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-27
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-1.02
Earnings History > 3 > eps Estimate
-0.875
Earnings History > 3 > eps Difference
-0.145
Earnings History > 3 > surprise Percent
-16.5714
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-07
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-1.39
Earnings History > 4 > eps Estimate
-0.73
Earnings History > 4 > eps Difference
-0.66
Earnings History > 4 > surprise Percent
-90.411
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-13
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.64
Earnings History > 5 > eps Estimate
-0.96
Earnings History > 5 > eps Difference
0.32
Earnings History > 5 > surprise Percent
33.3333
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-15
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-1.15
Earnings History > 6 > eps Estimate
-1.09
Earnings History > 6 > eps Difference
-0.06
Earnings History > 6 > surprise Percent
-5.5046
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-29
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-1.75
Earnings History > 7 > eps Estimate
-0.78
Earnings History > 7 > eps Difference
-0.97
Earnings History > 7 > surprise Percent
-124.359
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-1.27
Earnings History > 8 > eps Estimate
-0.8
Earnings History > 8 > eps Difference
-0.47
Earnings History > 8 > surprise Percent
-58.75
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-11
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-2.4376
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-10
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-1.5066
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-29
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-2.1
Earnings History > 11 > eps Estimate
-2.1
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-14
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-3
Earnings History > 12 > eps Estimate
-3.6
Earnings History > 12 > eps Difference
0.6
Earnings History > 12 > surprise Percent
16.6667
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-16
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-3
Earnings History > 13 > eps Estimate
-4.63
Earnings History > 13 > eps Difference
1.63
Earnings History > 13 > surprise Percent
35.2052
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-17
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-4.8
Earnings History > 14 > eps Estimate
-4.35
Earnings History > 14 > eps Difference
-0.45
Earnings History > 14 > surprise Percent
-10.3448
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-11-12
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-5.2646
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-07-13
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.45
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.45
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-05-17
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-15.6489
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate is ELI-002, a multivalent lymph node"targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trial to target seven Kirsten rat sarcoma viral oncogene homolog driver mutations. The company also develops ELI-007, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for the treatment of mutant b-raf murine sarcoma viral oncogene homolog B1-driven cancers; and ELI-008, a multivalent lymph node"targeted AMP peptide vaccine in preclinical studies for use in the treatment of mutated tumor protein p53 expressing cancers. Elicio Therapeutics, Inc. is headquartered in Boston, Massachusetts.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMarket Catalysts: Is DMLP benefiting from interest rate changes - Market Risk Report & Verified Momentum Stock Alerts baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$15.5
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Neutral
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Elicio Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.6
EPS Estimate
-0.68
EPS Difference
0.08
Surprise Percent
11.7647%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.